skip to main content
Idioma:

Resultados de 1 a 10 de 13  para Produção Intelectual da USP

Ordenado por: Ordenado por: RelevânciaOr hit Enter to replace sort method
Resultados 1 2 next page
Mostrar Somente
Refinado por: assunto: Microbiologia remover assunto: Vacinas Virais remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines
Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines

Giovanne Delechiave Mariângela de Oliveira Silva; Maria Fernanda de Castro Amarante; Denisse Esther Mallaupoma Camarena; Aléxia Adrianne Venceslau Carvalho; Luiz Henrique Catalani; Luis Carlos de Souza Ferreira

ACS Applied Nano Materials Washington, DC v. 7, n. 4, p. 4068-4077, 2024

Washington, DC American Chemical Society 2024

Item não circula. Consulte sua biblioteca.(Acessar)

2
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein
Material Type:
Artigo 		Adicionar ao Meu Espaço

Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein

Mariângela de Oliveira Silva Maria Fernanda Castro-Amarante; Alexia Adrianne Venceslau Brito Carvalho; Bianca da Silva Almeida; Isabela Pazotti Daher; Guilherme Antonio de Souza-Silva; Marcio Massao Yamamoto; Gabriela Koike; Edmarcia Elisa de Souza; Carsten Wrenger; Luis Carlos de Souza Ferreira; Silvia Beatriz Boscardin

Vaccines Basel v. 12, n. 4, art. 356, 14 p., 2024

Basel 2024

Item não circula. Consulte sua biblioteca.(Acessar)

3
Immune targets to stop future SARS-CoV-2 variants
Immune targets to stop future SARS-CoV-2 variants
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune targets to stop future SARS-CoV-2 variants

Milena Silva Souza Jéssica Pires Farias; Wilson Barros Luiz; Alexander Birbrair; Ricardo Durães-Carvalho; Jaime Henrique Amorim; Luis Carlos de Souza Ferreira

Microbiology Spectrum Washington, DC. v. 11, n. 6, art. e0289223, 11 p., 2023

Washington, DC American Society for Microbiology 2023

Item não circula. Consulte sua biblioteca.(Acessar)

4
The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
Material Type:
Artigo 		Adicionar ao Meu Espaço

The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant

Jéssica P. Farias Josilene R Pinheiro; Robert Andreata Santos; Mayanna M. C Fogaça; Ruth D. da Silva Brito; Edgar Ferreira da Cruz; Maria Fernanda de Castro Amarante; Samuel Santos Pereira; Shirley dos Samtos Almeida; Ludmila M Moreira; Rafael da Conceição Simões; Wilson B Luiz Wilson Barros Luiz; Alexander Birbrair; Aline Belmok; Bergmann M Ribeiro Bergmann Morais Ribeiro; Juliana T Maricato Juliana Terzi Maricato; Carla T Braconi Carla Torres Braconi; Luiz M. R Janini Luiz Mário Ramos Janini; Jaime Henrique Amorim; Luís Carlos de Souza Ferreira

Journal of Medical Virology Hoboken v. 95, n. 2, p. 1-10, 2023

Hoboken 2023

Item não circula. Consulte sua biblioteca.(Acessar)

5
Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster
Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster

Rafael Rahal Guaragna Machado Erika Donizette de Oliveira Candido; Andressa Simões Aguiar; Vanessa Nascimento Chalup; Patricia Romão Sanches; Erick Gustavo Dorlass; Deyvid Emanuel Amgarten; João Renato Rebello Pinho; Danielle Bruna Leal de Oliveira

Vaccines Basel v. 12, n. 2, art. 144,

Basel MDPI AG 2024

Item não circula. Consulte sua biblioteca.(Acessar)

6
Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine insights to the future
Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine insights to the future
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine insights to the future

Milena Silva Souza Jéssica Pires Farias; Robert Andreata Santos; Marianne Pereira Silva; Ruth Dálety da Silva Brito; Marcia Duarte Barbosa da Silva; Cristina Mendes Peter; Marcus Vinicius de França Cirilo; Wilson Barros Luiz; Alexander Birbrair; Paloma Oliveira Vidal; Maria Fernanda Castro Amarante; Erika Donizette de Oliveira Candido; Aldilene Silva Munhoz; Fernanda de Mello Malta; Erick Gustavo Dorlass; Rafael Rahal Guaragna Machado; Joao Renato Rebello Pinho; Danielle Bruna Leal de Oliveira; Juliana Terzi Maricato; Carla Torres Braconi; Luiz Mário Ramos Janini; Jaime Henrique Amorim; Luis Carlos de Souza Ferreira; Edison Luiz Durigon

Journal of Medical Virology Hoboken, NJ v. 96, n. 2, art. e29416, 9 p., 2024

Hoboken, NJ John Wiley & Sons, Inc. 2024

Item não circula. Consulte sua biblioteca.(Acessar)

7
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape

Jamille Ramos Oliveira Cesar Manuel Remuzgo Ruiz; Rafael Rahal Guaragna Machado; Alysson Henrique Urbanski; Jhosiene Yukari Magawa; Isabela Pazotti Daher; Gabriela Justamante Händel Schmitz; Helen Andrade Arcuri; Marcelo Alves Ferreira; Greyce Luri Sasahara; Giuliana Xavier de Medeiros; Roberto Carlos Vieira da Silva Júnior; Daniela Santoro Rosa; Helder Takashi Imoto Nakaya; Gabriele Gadermaier; Verônica Coelho; Keity Souza Santos; Edison Luiz Durigon; Silvia Beatriz Boscardin; Deborah Schechtman; Edecio Cunha Neto; Jorge Elias Kalil Filho; Veronica Porto Carreiro de Vasconcellos Coelho

Frontiers in Immunology Lausanne v. 13, art. 1010105, p. 1-15, 2023

Lausanne 2023

Acesso online. A biblioteca também possui exemplares impressos.

8
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation

Monica Josiane Rodrigues de Jesus Marianna Teixeira de Pinho Favaro; Aléxia Adrianne Venceslau Brito Carvalho; Maria Fernanda de Castro Amarante; Bianca da Silva Almeida; Mariângela de Oliveira Silva; Robert Andreata Santos; Cecilia Gomes Barbosa; Samantha Carvalho Maia Brito; Lucio Holanda Gondim de Freitas Junior; Silvia Beatriz Boscardin; Luís Carlos de Souza Ferreira

Nanomedicine: Nanotechnology, Biology and Medicine Philadelphia v. 45, art. 102595, p. 1-11, 2022

Philadelphia 2022

Item não circula. Consulte sua biblioteca.(Acessar)

9
The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
Material Type:
Artigo 		Adicionar ao Meu Espaço

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population

Jéssica Pires Farias Robert Andreata-Santos; Ruth Dalety da Silva Brito; Milena Silva Souza; Mayanna Moreira Costa Fogaça; Josilene Ramos Pinheiro; Edgar Ferreira da Cruz; Willian Liang; Rafael da Conceição Simões; Wilson Barros Luiz; Alexander Birbrair; Paloma Oliveira Vidal; Juliana Terzi Maricato; Carla Torres Braconi; Luiz Mário Ramos Janini; Jaime Henrique Amorim; Luis Carlos de Souza Ferreira

Microbiology Spectrum WASHINGTO, DC. v. 11, n. 6, art. e02857-23, 16 p., 2023

Washington, DC American Society for Microbiology 2023

Item não circula. Consulte sua biblioteca.(Acessar)

10
Severe acute respiratory syndrome Coronavirus 2 variants of concern a perspective for emerging more transmissible and vaccine-resistant strains
Severe acute respiratory syndrome Coronavirus 2 variants of concern a perspective for emerging more transmissible and vaccine-resistant strains
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe acute respiratory syndrome Coronavirus 2 variants of concern a perspective for emerging more transmissible and vaccine-resistant strains

Anacleto Silva de Souza Vitor Martins de Freitas Amorim; Gabriela D. A Guardia; Filipe Ferreira dos Santos; Henning Ulrich; Pedro A. F Galante; Robson Francisco de Souza; Cristiane Rodrigues Guzzo Carvalho

Viruses Basel v. 14, n. 4, art. 827, p. 1- 21, 2022

Basel 2022

Item não circula. Consulte sua biblioteca.(Acessar)

Resultados de 1 a 10 de 13  para Produção Intelectual da USP

Ordenado por: Ordenado por: RelevânciaOr hit Enter to replace sort method
Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Disponível na Biblioteca (2)
  2. Recursos Online (1)

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Ferreira, L
  2. Durigon, E
  3. Boscardin, S
  4. Luiz, W
  5. Machado, R

Neste Assunto:

  1. Covid-19
  2. Vacinas Virais
  3. Microbiologia
  4. Anticorpos
  5. Variação Genética

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.